Dr. Andrea K. Ng
Claim this profileDana-Farber Cancer Institute
Studies Diffuse Large B-Cell Lymphoma
Studies Lymphoma
4 reported clinical trials
4 drugs studied
Area of expertise
1Diffuse Large B-Cell Lymphoma
BCL2 positive
Stage II
Stage I
2Lymphoma
BCL2 positive
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Andrea K. Ng is currently running
Radiation Therapy
for B-Cell Lymphoma
Participants are invited to take part in this research study because they have relapsed (cancer has come back) or refractory (cancer has not responded to treatment) B-cell Lymphoma and will be undergoing CAR T-cell Therapy. This research is being done to see if a new radiation therapy administration schedule will positively impact the logistics, time, cost, and side effects of radiation therapy. In this research study, participants will receive radiation therapy once weekly for 5 weeks. This is a novel administration schedule and we're looking to see how this schedule impacts side effects participants may experience, the time spent receiving radiation therapy, how much radiation therapy participants can receive, and how effective this new schedule is.
Recruiting1 award N/A
Low-Dose Radiotherapy
for Multiple Myeloma with Bone Pain
This phase II trial studies how well low-dose radiotherapy works in treating bone pain in patients with multiple myeloma that has spread to the bone. Radiation therapy uses high energy x-rays, gamma rays, neutrons, protons, or other sources to kill tumor cells and shrink tumors. Low-dose radiotherapy may be more convenient for patients and their families, may not interfere as much with the timing of chemotherapy, and may have less chance for short term or long-term side effects from the radiation.
Recruiting1 award N/A6 criteria
More about Andrea K. Ng
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Andrea K. Ng has experience with
- Echo/Stress Echo
- Adaptive Bridging Radiation Therapy (ABRT)
- Low-Dose Radiotherapy
- Radiation Therapy
Breakdown of trials Andrea K. Ng has run
Diffuse Large B-Cell Lymphoma
Lymphoma
Cancer
Non-Hodgkin's Lymphoma
Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea K. Ng specialize in?
Andrea K. Ng focuses on Diffuse Large B-Cell Lymphoma and Lymphoma. In particular, much of their work with Diffuse Large B-Cell Lymphoma has involved BCL2 positive patients, or patients who are Stage II.
Is Andrea K. Ng currently recruiting for clinical trials?
Yes, Andrea K. Ng is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Andrea K. Ng has studied deeply?
Yes, Andrea K. Ng has studied treatments such as Echo/Stress Echo, Adaptive Bridging Radiation Therapy (ABRT), Low-Dose Radiotherapy.
What is the best way to schedule an appointment with Andrea K. Ng?
Apply for one of the trials that Andrea K. Ng is conducting.
What is the office address of Andrea K. Ng?
The office of Andrea K. Ng is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.